Celera Diagnostics Revenues up, Losses Down in Q3 of FY2004 | GenomeWeb

NEW YORK, April 27 (GenomeWeb News) - Celera Diagnostics reported increased revenues and smaller losses for the fiscal year 2004 third quarter today.

 

The company, a joint venture of Applied Biosystems and Celera Genomics, both units of Applera, had revenues of $7.5 million, up from $4.3 million during the same quarter last year.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: genes involved in histone deacetylation in Arabidopsis, effects of pathogenic presenilin-1 mutations, and more.

After a study finds DNA from antibiotic-resistant bacteria in Beijing smog, residents there worry, according to the New York Times.

Canada begins its search for a chief government science advisor, Nature News reports.

A company is using facial recognition tools to identify genetic disorders from pictures, Technology Review reports.